Navigation Links
EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
Date:10/22/2007

TARRYTOWN, N.Y., Oct. 22 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Dr. Ben Tseng, Chief Scientific Officer, will present the results of studies examining the combination of EPC2407 with cancer therapeutics in preclinical animal models at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco, CA on October 24, 2007. EPC2407 is EpiCept's novel small molecule vascular disruption agent and apoptosis inducer for the treatment of patients with advanced solid tumors and lymphomas that recently completed enrollment in a Phase Ia single agent trial.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

The preclinical studies examined the effectiveness of combining EPC2407 with an anti-angiogenesis inhibitor, Avastin(R) or Sutent(R), or with the chemotherapeutic agent cisplatin. EPC2407 was administered in combination with a cancer therapeutic agent in mouse xenograft models of human non-small cell lung carcinomas and human breast carcinomas. These studies indicated significantly enhanced anti-tumor activity when EPC2407 was added to the therapeutic regimen, compared with either agent administered alone, which resulted in increased median survival and number of tumor-free animals well after the end of treatment (>2.5 months). The results demonstrated additive to synergistic activity when EPC2407 is used in combination with these cancer therapeutics.

These results strongly support the clinical testing of EPC2407 in combination with different anti-cancer agents. Advancement of EPC2407 in clinical trials to Phase Ib combination studies is planned to initiate in early 2008.

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. EpiCept has a staged portfolio of pharmaceutical product candidates
'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. EpiCept Accelerates Development of Phase I Clinical Study for Cancer
2. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
3. Researchers Present Ways To Reduce The Risk Of Dementia
4. Researchers Present Data Regarding The Efficiency Of Herbs
5. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
6. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
7. Drug Reactions First Present Themselves In The Mouth
8. Reminiscing Into The Past Makes You Dissatisfied With The Present
9. Living In The Past Indicates Dissatisfaction With Present
10. Movies Represent Coma In A Wrong Way
11. Onchocerciasis: Presentation And Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... LunaDress.co.uk has updated its blog to provide professional shopping tips on ... models at LunaDress.co.uk come with big discounts, up to 80 percent ... turn out to be a most exciting memory and can show ... surprise to a wedding. On the updated fashion blog, ladies can ... a big day . , Going out with friends to a ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
(Date:12/25/2014)... Dec. 24, 2014 (HealthDay News) -- Among early stage ... less than half of one percent will eventually develop ... analysis reveals. The finding comes from a review ... 1998 and 2007, and it suggests that the risk ... what experts had previously thought. "The frequency of ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the experience ... business has introduced its new collection of 2015 prom ... The new prom outfits are guaranteed to contain the ... are specially designed for 2015. Anyone who wants to ... its website before Jan. 26, 2015, the deadline of ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch ... and coolest mobile applications on the iOS, Android, and Windows ... NewsWatch, conducted the app review and shared with viewers how ... , The old saying goes, “A picture says a thousand ... can describe a single image, because each picture holds a ...
Breaking Medicine News(10 mins):Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... Tube-Feeding Best-Practice Recommendations NEW ORLEANS, Feb. 3 ... HealthCare Nutrition and the American Society for Parenteral ... launch of a new initiative to promote safe ... designed to raise awareness of key steps that ...
... LEXINGTON, Ky., Feb. 3 Just because the economy isn,t ... a Valentine,s surprise for that,special someone. Now,s the time ... from discounted treatments to complimentary services. Roses wilt,and chocolates melt, ... not only a,romantic gift but a healthful one too. , ...
... out the bumps in aesthetic skin care with its latest offering. ... the UniForm handpiece, recently approved by the FDA for cellulite treatment. ... ... seeking painless cellulite treatment, New York City based Juva Skin and ...
... (February 2, 2009) New research published in the ... College of Surgeons suggests that a traditional, "open" ... for the majority of patients with acute appendicitis, contrary ... are performed in the United States each year to ...
... Feb. 2 Smith & Nephew,s Advanced Wound ... announced that the U.S. Court of Appeals for the Federal ... 1 negative pressure wound therapy system marketed by Blue Sky ... Sky in May 2007."Smith & Nephew welcomes the appeals court ...
... Living: The Financial Options Guide Now Available at Sunrise ... Senior Living (NYSE: SRZ ) now offers ... families identify ideas for affording senior care in today,s ... Living: The Financial Options , is available at Sunrise ...
Cached Medicine News:Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 2Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 3Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 4Health News:Rev Up the Romance this Valentine's Day with Savvy Spa Savings 2Health News:Juva Skin Banishes Bumps with New UniForm Cellulite Therapy Handpiece 2Health News:Treating appendicitis by laparoscopic surgery may not be worth the cost 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 3Health News:Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide 2
(Date:12/24/2014)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... preliminary financial results for the first quarter of ... Ended September 30, 2014 Financial Highlights: , ... in 1Q14 with gross margins improved to 52% ...
(Date:12/24/2014)... 24, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that on December 24, 2014 it closed ... The Company raised approximately $2.3 million in gross ... the net proceeds from the offering to fund ...
(Date:12/24/2014)... Dec. 24, 2014  Conkwest, Inc., the Natural ... proprietary Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) ... Patrick Soon-Shiong , NantWorks founder, physician scientist and ... to purchase approximately $48 million of the Company,s ... investment, he will be named Co-Chairman of the ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5
... BARBARA, Calif., Sept. 15, 2011 Inogen has won ... services and devices to patients in TRICARE,s 21-state ... to offer the Inogen One portable oxygen ... families. TRICARE West (TriWest) covers 2.7 million ...
... The Liver Meeting ® is the premier meeting in the ... new drugs, novel treatments, and the results from pilot and ... some form of liver disease, but fortunately, the research community ... treatments for patients.   At this year,s meeting, ...
Cached Medicine Technology:Inogen Awarded Contract to Service TRICARE West Oxygen Therapy Patients 2The 62nd Annual Meeting of the American Association for the Study of Liver Diseases 2
Designed to give maximum drying area while taking up minimal bench space....
The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm....
Thermostatically controlled, large capacity surface to quickly evaporate water and solvents from slides and mounting media....
Compact instrument that quickly dries racks of slides using warm air....
Medicine Products: